Since interstitial pneumonia complicated by anti-MDA5 antibody-positive dermatomyositis is often severe and results in respiratory failure due to RP-ILD, early implementation of potent immunosuppressive therapy should be considered. Here, IFIH1 is linked to interstitial lung disease.